MHLW Orders Label Revisions for Takecab to Include Pancytopenia to ADR List

October 30, 2019
The Ministry of Health, Labor and Welfare (MHLW) ordered label revisions on October 29, relating to adverse reactions for a group of drugs including Takeda Pharmaceutical’s acid reducer Takecab (vonoprazan). In a notification issued on the day, the MHLW ordered...read more